Literature DB >> 33303354

Psychological Distress in Women Living with Polycystic Ovary Syndrome: The Role of Illness Perceptions.

Rebecca S Light1, Joseph Chilcot2, Emily McBride3.   

Abstract

INTRODUCTION: Polycystic ovary syndrome (PCOS) is an endocrine and metabolic condition linked to increased risk of anxiety and depression (psychological distress). This study examined the relationship between illness perceptions and psychological distress in women living with PCOS.
METHODS: We used a cross-sectional survey to assess psychological distress (Hospital Anxiety and Depression Scale) and illness perceptions (Illness Perception Questionnaire-Revised) in women living with PCOS in the UK (N = 487). Hierarchical multiple linear regression tested the associations between illness perceptions and psychological distress, adjusting for age, years since PCOS diagnosis, education, body mass index, current depression, and current anxiety disorder.
RESULTS: In the fully adjusted regression model, illness perceptions explained 18.6% of the variance in psychological distress, F(7,458) = 21.0, p < .001. Reporting more symptoms (B = 0.226), higher perceived consequences (B = 0.204), lower personal control (B = -0.184), and lower illness coherence (B = -0.127) were significantly associated with higher psychological distress (all p < .001).
CONCLUSIONS: Illness perceptions may play an important role in psychological distress, even after adjusting for relevant demographics and clinical characteristics. Our findings highlight key areas where researchers and clinicians could develop targeted self-management interventions for women with PCOS, focused on altering maladaptive illness perceptions to reduce psychological burden.
Copyright © 2020 Jacobs Institute of Women's Health. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2020        PMID: 33303354     DOI: 10.1016/j.whi.2020.11.003

Source DB:  PubMed          Journal:  Womens Health Issues        ISSN: 1049-3867


  1 in total

1.  Anxiety and Depression in Women with Polycystic Ovary Syndrome.

Authors:  Paweł Dybciak; Ewa Humeniuk; Dorota Raczkiewicz; Jan Krakowiak; Artur Wdowiak; Iwona Bojar
Journal:  Medicina (Kaunas)       Date:  2022-07-16       Impact factor: 2.948

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.